Introduction
Uncomplicated wound infections account for almost 200 million physician visits in the USA annually, with treatment costs estimated to be >$350 million each year. 1 Patients with uncomplicated wound infections are commonly treated with topical antimicrobial therapy for several reasons, including the high local drug concentration at the site of the infection, 2 the low incidence of systemic side effects, 3 and good patient compliance.
Although there is little debate about the need to keep these wounds clean and provide a moist environment for wound healing, 4 there is still controversy over the use of topical antibiotics, including the possibility of local allergic reactions to topically applied antimicrobials or their vehicles, poor penetration into the skin, and emergence of resistant organisms with antibiotics exposure.
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Tong et al Saco et al concluded from their systematic review and meta-analysis that petroleum should be used instead of topical antibiotics for prevention of postsurgical wound infections. 6 The Centers for Disease Control and Prevention 2017 guideline for the prevention of surgical site infections (SSIs) compiled by the Healthcare Infection Control Practices Advisory Committee also recommended against the use of topical antimicrobial agents for prevention of SSIs. However, these recommendations were based on low-quality evidence. 7 On the other hand, through their systematic review and metaanalysis, Heal et al concluded topical antibiotics probably prevent SSIs compared to no antibiotic or with antiseptic. 8 Because of the controversy in the use of topical antibiotics for prevention of SSIs, we conducted a systematic review and a meta-analysis to examine the available evidence of the clinical effectiveness of topical antibiotic use for prevention of uncomplicated wound infections.
Materials and methods
Literature search
The authors conducted this systematic review and metaanalysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations. 9 One of the authors (EMJ) searched Pubmed, Google Scholar, and SCOPUS (which includes content from the Embase database). Additionally, Cochrane, ClinicalTrials.gov, International Clinical Trials Registry Platform, National Technical Information Service, and the National Guidelines Clearinghouse were searched. The search was limited to human subjects and English language literature published in and after 1980. The last search was performed in July 2017.
The following search strategy comprising the Medical Subject Headings (MeSH) and keywords was used: ("skin/ injuries" [Majr] OR "wound healing" [Majr] OR "wound infection/prevention and control" [Majr] OR "infection control/methods" [Majr] OR "bacterial infections/prevention and control" [Majr]) OR ("uncomplicated" AND ["wound" OR "laceration"] OR "infection prophylaxis" OR "infection prevention") AND ("anti-infective agents, local" [MeSH] OR "anti-bacterial agents" [MeSH] OR "triple antibiotic" OR "neosporin" OR "polysporin") AND ("administration, topical" [MeSH] OR "administration, cutaneous" [MeSH] OR "topical" OR "cutaneous"). References of all included articles were scanned for additional studies. Articles focusing on dermatologic surgeries were included. Articles focusing on treatment rather than prevention and those not focusing on uncomplicated skin infection were excluded.
Selection
We included randomized controlled trials and quasirandomized trials (QRTs) with no limitation for age, sex, or country of origin. We defined uncomplicated wounds as wounds that were acute and uninfected. We defined prophylaxis or prevention as administration of topical antibiotics to the wounds before development of infection. We included studies that examined uncomplicated wounds and had topical antibiotics in the form of ointment, cream, paste, or gel in at least one of the study arms. Studies that used lotion, solution, tincture, foam, paste, powder, tulle, aerosols, or antibiotic-impregnated dressing were included if one of the study arms used ointment, cream, paste, or gel as one of the topical antibiotics. We also included studies that had an antiseptic (e.g., silver sulfadiazine cream, povidone-iodine) or a placebo or no treatment as a comparison arm. Wounds that were already infected at the time of enrollment and burn wounds were excluded. Studies on artificially created wounds and those that involved catheters were also excluded.
Outcomes
The primary outcome was the development of postsurgical or post-procedural wound infections.
Trial selection and data extraction
Three reviewers (TSL, KDPH, and MZ) independently reviewed the 4314 articles found during the initial database searching. The data were then extracted based on eligibility criteria, data sources, study methods, sample sizes, types of intervention, post-procedural wound infection rates, and authors' conclusions.
Assessment of risk of bias
The three reviewers who performed the trial selection and data extraction also evaluated the included studies for the risk of bias (selection bias, performance bias, detection bias, attrition bias, and reporting bias) based on Cochrane Collaboration's tool for assessing risk of bias. 10 
Statistical analysis
Mantel-Haenszel random-effects models were used to pool dichotomous count data across studies and estimate the risk ratios (RRs), risk differences (RDs), and their corresponding 95% CIs to assess relative and absolute effect sizes of efficacy. Our primary exposure was the use of any topical antibiotics, and primary outcome was development of wound infection following surgical procedure. I 2 and t 2 were calculated to assess heterogeneity among the included studies. We stratified 
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Topical antibiotics for prevention of wound infection analysis by the type of comparison (placebo and antiseptics) and also summarized results by tested antimicrobial agents. We performed meta-analysis if more than or equal to three studies were available for the same analysis group. Numbers needed to treat (NNTs) were also calculated based on RDs for primary analysis. Statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC, USA), and forest plot was created using Review Manager (RevMan) version 5.3 (Cochrane Collaboration, Copenhagen, Denmark).
Results
The results of the literature search are shown in the flowchart in Figure 1 . Initially, 4314 potentially relevant articles were identified through our initial database searching. After reviewing the titles and abstracts, 4274 articles were excluded and 40 full-text articles were eligible for detailed examination. Out of the 40 full-text articles, 28 articles were excluded based on the reasons cited in Figure 1 . Eight randomized controlled trials and four QRTs met the criteria for inclusion in the systematic review. The characteristics of the 12 studies included in the systematic review are summarized in Table 1 . Among them, eight studies reported comparison between topical antimicrobials and placebo, one reported comparison between topical antimicrobials and topical antiseptics, and three studies included both placebo and topical antiseptics as comparison arms. No prophylactic arm with antibiotic ointment or cream, n=4 Topical antibiotics for decolonization, n=3 Topical antibiotics to peritoneal dialysis and hemodialysis catheter sites, n=4
Topical antibiotics for treatment and not for prophylaxis, n=1 Polypropylene mesh used, n=1 Antiseptic compared to antiseptic (no antibiotic or placebo arm), n=1
Three antibiotics compared to single antibiotic (no placebo or antiseptic arm), n=1
Mixture of antiseptic and antibiotic compared to antiseptic (no placebo arm), n-=1 
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Risk of bias
Out of the 12 included studies, we concluded 2 were at high risk of bias, 11,20 4 were at unclear risk, 13, 14, 17, 22 and 6 were at low risk. 12, 15, 16, 18, 19, 21 We found detailed descriptions were lacking for random sequence generation and/or allocation concealment in four studies that were considered at unclear risk. There were two studies that were considered at high risk because of their open-label design and both studies were in the category of QRTs. None of the high-risk or unclear risk studies committed attrition bias or reporting bias.
Efficacy of topical antibiotics compared to placebo
In total, 11 studies (5240 wounds) were pooled to compare the effects of topical antibiotics versus placebo on uncomplicated wounds (Figures 2 and 3) . Meta-analysis for RRs showed statistically significant relative risk reduction (pooled RR: 0.57 [95% CI: 0.37 to 0.86]; p=0.01), while meta-analysis for RD demonstrated statistically significant but small absolute risk reduction (pooled RD: −3.1% [95% CI: −5.8% to −0.34%]; p=0.03). Estimated NNT based on absolute risk reduction was 32.4 (95% CI: 17.2 to 294.4). Two studies could not be included in the meta-analysis for RRs because of zero count of event. Of the 11 studies, 1 was at high risk, 4 were at unclear risk, and 6 were at low risk of bias.
Efficacy of topical antibiotics compared to topical antiseptics
Four studies (total of 1037 wounds) reported comparison between topical antibiotics and topical antiseptics (Figures 4  and 5 ). Meta-analysis for RRs showed statistically significant relative risk reduction (pooled RR: 0.56 [95% CI: 0.34 to 0.91]; p=0.02), while meta-analysis for RD did not show significant absolute risk reduction (pooled RD: −3.7% [95% CI: −7.9% to +0.6%]; p=0.09). Of the four studies, one was at high risk, one was at unclear risk, and two were at low risk of bias. Figure 6 summarizes the results of included studies by the type of antimicrobial agents used, compared to placebo or antiseptics. Since no specific antimicrobial agent had adequate number of studies, we could not perform metaanalysis of individual agents.
Summary of included studies by antimicrobial agents
Discussion
Our systematic review and meta-analysis found that topical antibiotics in comparison to placebo or antiseptics reduced postsurgical procedure infection risk, albeit a small absolute risk reduction. Because the NNT to prevent one additional 
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Campbell et al 11 Dire et al 12 Dixon et al 13 Draelos et al 14 Heal et al 15 Kamath et al 16 Khalighi et al 17 Langford et al 18 Maddox et al 19 Smack et al 21 Taylor 
Topical antibiotics Placebo Risk difference M-H, Random, 95% CI Risk difference M-H, Random, 95% CI Events Total Events Total Weight Campbell et al 11 Dire et al 12 Dixon et al 13 Draelos et al 14 Heal et al 15 Kamath et al 16 Khalighi et al 17 Langford et al 18 Maddox et al 19 Smack et al 21 Taylor et al It was not possible to draw conclusions regarding the effect of topical antibiotics on complicated wound infections or uncomplicated wounds that had been infected prior to application of topical antibiotics, since this was outside the scope of this systematic review and meta-analysis. 
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Subgroup
Campbell et al 11 Dixon et al 13 Dire et al 12 Dire et al 12 Dire et al 12 Dire et al 12 Maddox et al 19 Langford et al 18 Langford et al 18 Pradhan and Agrawal 20 Heal et al 15 Kamath et al 16 Khalighi et al 17 Khalighi et al 17 Smack et al 21 Draelos et al 14 Taylor 
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Our study has a few limitations. First, only studies that were published in the English language since 1980 were included, therefore we could have excluded articles that were pertinent to our review. Second, many studies assessing the efficacy of topical antibiotics for wounds have varying study designs, which does not allow for direct comparisons. In addition, definitions of wound or description of wounds included were not always clearly defined within the publications. Another limitation of our study was we did not investigate the adverse reactions to topical antibiotics in comparison to placebo, such as allergic contact dermatitis. However, the incidence of adverse reactions related to topical antibiotics is known to be low 23, 24 and there were very few studies that addressed this topic.
One of the strengths of our review was the inclusion of studies that used antibiotic cream, ointment paste, or gel as they are the most commonly used vehicles for topical antibiotics that allow for a high concentration at the site of infection. Another strength was comparison of individual topical antibiotics to placebo or antiseptic, which was not done in similar studies. 6, 8 While the evidence presented demonstrates that topical antibiotics are effective for prevention of wound infections after surgical procedures, clinicians must take into consideration the toxicity risk of the compound, efficacy, and that there is little information on systemic absorption of the antibiotics. Furthermore, route of administration of antibiotics should be carefully considered. As discussed above, this systematic review focused on topical application of antibiotics because this route of administration is the most commonly used for uncomplicated skin infections.
Conclusion
Topical antibiotics were effective in reducing the risk of infections in uncomplicated wounds compared to placebo or antiseptics, but the absolute risk reduction was minimal compared to placebo. In addition, there was no statistically significant absolute reduction when compared to antiseptics. Considering the global emergence of antimicrobial resistance, judicious use of topical antibiotics is encouraged, and antiseptics should be considered as a reasonable alternative to topical antibiotics.
